Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
28.50
+0.50 (1.79%)
At close: May 29, 2026, 4:00 PM EDT
30.00
+1.50 (5.26%)
After-hours: May 29, 2026, 5:13 PM EDT

COAG Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, COAG stock has a consensus rating of "Strong Buy" and an average price target of $41.75. The average 1-year stock price forecast is 46.49% higher than the current stock price, while the lowest is $36 (+26.32%) and the highest is $50 (+75.44%).

Price Target: $41.75 (+46.49%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$36$41.75$40.5$50
Change+26.32%+46.49%+42.11%+75.44%

Analyst Ratings

The average analyst rating for COAG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '26
Strong Buy4
Buy0
Hold0
Sell0
Strong Sell0
Total4

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Evercore ISI
Evercore ISI
Buy
Initiates
$50
BuyInitiates$50+75.44%May 26, 2026
Wedbush
Wedbush
Buy
Initiates
$42
BuyInitiates$42+47.37%May 26, 2026
Jefferies
Jefferies
Buy
Initiates
$39
BuyInitiates$39+36.84%May 26, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$36
BuyMaintains$36+26.32%May 26, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.